Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Potential mechanisms of atypical antipsychotic-induced hypertriglyceridemia
Hu Yan, Jindong Chen, Xiaoyan Zheng
Psychopharmacology (2013) Vol. 229, Iss. 1, pp. 1-7
Closed Access | Times Cited: 46

Showing 1-25 of 46 citing articles:

Pathophysiological mechanisms of increased cardiometabolic risk in people with schizophrenia and other severe mental illnesses
David C. Henderson, Brenda Vincenzi, Norte García Andrea, et al.
The Lancet Psychiatry (2015) Vol. 2, Iss. 5, pp. 452-464
Closed Access | Times Cited: 251
Weight gain and antipsychotics: a drug safety review
Richard Musil, Michael Obermeier, Paul Russ, et al.
Expert Opinion on Drug Safety (2014) Vol. 14, Iss. 1, pp. 73-96
Closed Access | Times Cited: 182
A Comprehensive Update on the Chylomicronemia Syndrome
Ronald Goldberg, Alan Chait
Frontiers in Endocrinology (2020) Vol. 11
Open Access | Times Cited: 96
Atypical antipsychotic drugs cause abnormal glucose and lipid metabolism independent of weight gain
Ye Yang, Renrong Wu
European Archives of Psychiatry and Clinical Neuroscience (2025)
Closed Access | Times Cited: 1
Pharmacological treatment for generalized anxiety disorder in adults: an update
Jennifer A Reinhold, Karl Rickels
Expert Opinion on Pharmacotherapy (2015) Vol. 16, Iss. 11, pp. 1669-1681
Closed Access | Times Cited: 72
Serum metabolite profile associates with the development of metabolic co-morbidities in first-episode psychosis
Tommi Suvitaival, Outi Mantere, Tuula Kieseppä, et al.
Translational Psychiatry (2016) Vol. 6, Iss. 11, pp. e951-e951
Open Access | Times Cited: 39
Metabolic Disturbances Independent of Body Mass in Patients with Schizophrenia Taking Atypical Antipsychotics
Shi Hyun Kang, Jong Il Lee
Psychiatry Investigation (2015) Vol. 12, Iss. 2, pp. 242-242
Open Access | Times Cited: 39
Atypical Antipsychotics and the Risk of Hyperlipidemia: A Sequence Symmetry Analysis
Yoshinori Takeuchi, Kazuhiro Kajiyama, Chieko Ishiguro, et al.
Drug Safety (2015) Vol. 38, Iss. 7, pp. 641-650
Closed Access | Times Cited: 34
Olanzapine-depot administration induces time-dependent changes in adipose tissue endocrine function in rats
Kateřina Horská, Jana Kučerová, Zuzana Babinská, et al.
Psychoneuroendocrinology (2016) Vol. 73, pp. 177-185
Closed Access | Times Cited: 32
Changes in Body Fat and Related Biochemical Parameters Associated With Atypical Antipsychotic Drug Treatment in Schizophrenia Patients With or Without Metabolic Syndrome
Elena G. Kornetova, А. Н. Корнетов, Irina A. Mednova, et al.
Frontiers in Psychiatry (2019) Vol. 10
Open Access | Times Cited: 32
Risk factors for drug-related acute pancreatitis: an analysis of the FDA adverse event reporting system (FAERS)
Lin Zhang, Wei Mao, Dan Liu, et al.
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 10
Metabolic syndrome in patients taking clozapine: prevalence and influence of catechol-O-methyltransferase genotype
Yi Zhang, Meijuan Chen, Jun Chen, et al.
Psychopharmacology (2014) Vol. 231, Iss. 10, pp. 2211-2218
Closed Access | Times Cited: 33
Effects of olanzapine treatment on lipid profiles in patients with schizophrenia: a systematic review and meta-analysis
Rong Li, Yiqi Zhang, Wenqiang Zhu, et al.
Scientific Reports (2020) Vol. 10, Iss. 1
Open Access | Times Cited: 27
Hypertriglyceridemia-Associated Drug-Induced Acute Pancreatitis
Mohamed A. Elkhouly, Miguel Salazar, C. Roberto Simons-Linares
Pancreas (2018) Vol. 48, Iss. 1, pp. 22-35
Closed Access | Times Cited: 27
Early insulin resistance predicts weight gain and waist circumference increase in first-episode psychosis – A one year follow-up study
Jaakko Keinänen, Outi Mantere, Tuula Kieseppä, et al.
Schizophrenia Research (2015) Vol. 169, Iss. 1-3, pp. 458-463
Closed Access | Times Cited: 26
Atypical antipsychotics: A review on the prevalence, monitoring, and management of their metabolic and cardiovascular side effects
Joyce Wei Xin Chong, Earl Hsien-Jie Tan, Chia Eng Chong, et al.
Mental Health Clinician (2016) Vol. 6, Iss. 4, pp. 178-184
Open Access | Times Cited: 21
Comparison of the Metabolic Characteristics of Newer Second Generation Antipsychotics
J Gréger, Traci Aladeen, Emily Lewandowski, et al.
Journal of Clinical Psychopharmacology (2020) Vol. 41, Iss. 1, pp. 5-12
Closed Access | Times Cited: 18
Fatty acid transport protein-2 inhibitor Grassofermata/CB5 protects cells against lipid accumulation and toxicity
Nipun Saini, Paul N. Black, David Montefusco, et al.
Biochemical and Biophysical Research Communications (2015) Vol. 465, Iss. 3, pp. 534-541
Open Access | Times Cited: 20
Effects of risperidone treatment on the expression of hypothalamic neuropeptide in appetite regulation in Wistar rats
Canan Kurşungöz, Mehmet Ak, Tülin Yanık
Brain Research (2014) Vol. 1596, pp. 146-155
Closed Access | Times Cited: 20
Aripiprazole-induced adverse metabolic alterations in polyI:C neurodevelopmental model of schizophrenia in rats
Kateřina Horská, Jana Kučerová, Eva Dražanová, et al.
Neuropharmacology (2017) Vol. 123, pp. 148-158
Closed Access | Times Cited: 18
Quetiapine-induced hypertriglyceridaemia causing acute pancreatitis
John Mark Franco, Saraschandra Vallabhajosyula, Timothy John Griffin
BMJ Case Reports (2015), pp. bcr2015209571-bcr2015209571
Open Access | Times Cited: 13
Vitamin D supplementation is effective for olanzapine-induced dyslipidemia
Zijian Zhou, Takuya Nagashima, Chihiro Toda, et al.
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 4
Body and liver fat content and adipokines in schizophrenia: a magnetic resonance imaging and spectroscopy study
Jong‐Hoon Kim, Junghyun Kim, Pil-Whan Park, et al.
Psychopharmacology (2017) Vol. 234, Iss. 12, pp. 1923-1932
Closed Access | Times Cited: 12
The Pharmacokinetic and Safety Profiles of Blonanserin in Healthy Chinese Volunteers After Single Fasting Doses and Single and Multiple Postprandial Doses
Xia Chen, Hongyun Wang, Ji Jiang, et al.
Clinical Drug Investigation (2014) Vol. 34, Iss. 3, pp. 213-222
Closed Access | Times Cited: 8
Exercise intervention for preventing risperidone-induced dyslipidemia and gluco-metabolic disorders in female juvenile rats
Emma Sylvester, Weijie Yi, Mei Han, et al.
Pharmacology Biochemistry and Behavior (2020) Vol. 199, pp. 173064-173064
Closed Access | Times Cited: 8
Page 1 - Next Page

Scroll to top